Oxaliplatin
Who holds supplier records for Oxaliplatin? 19 organisations hold a current record for Oxaliplatin: an active US FDA Type II Drug Master File or a CEP. A further 7 organisations have only historical (inactive) DMF filings. 14 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (7), China (4), Germany (1), Netherlands (1) and 3 other countries (3); not recorded for 3.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Oxaliplatin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/oxaliplatin
Reading the evidence
- 19 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 9 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (19)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Oxaliplatin. Country is the organisation's recorded country, not necessarily the manufacturing site.
- KUNMING GUIYAN PHARMACEUTICAL CO LTDChinaCEPActive DMF 41028, 29430 · latest filing Feb 2025
- HERAEUS PRECIOUS METALS GMBH AND CO KGGermanyCEP Company GMP cert on recordActive DMF 19633 · latest filing Jul 2006
- Hetero Labs LimitedIndiaCEP Company GMP cert on recordActive DMF 28913 · latest filing Dec 2014
- JIANGSU HENGRUI PHARMACEUTICALS CO LTDChinaCEP Company GMP cert on recordActive DMF 20665 · latest filing Jul 2007
- Laurus Labs LimitedIndiaCEP Company GMP cert on recordActive DMF 22387 · latest filing Dec 2008
- Qilu Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 23530 · latest filing Feb 2010
- SHILPA PHARMA LIFESCIENCES LTDIndiaCEPActive DMF 23563 · latest filing Feb 2010
- Sun Pharmaceutical Industries LimitedIndiaCEP Company GMP cert on recordActive DMF 19648 · latest filing Aug 2006
- TAPI NL BVNetherlandsCEPActive DMF 19559 · latest filing Jun 2006
- UMICORE ARGENTINA SACEPActive DMF 28043 · latest filing Mar 2014
- Emcure Pharmaceuticals LimitedIndia Company GMP cert on recordActive DMF 24559 · latest filing Jan 2011
- PLIVA-LACHEMA ASActive DMF 19594 · latest filing Jul 2006
- TANAKA KIKINZOKU KOGYOActive DMF 10040 · latest filing Jan 1993
- VERANOVA LPUnited KingdomActive DMF 16952 · latest filing Nov 2003
- VUAB PHARMA ASSwedenActive DMF 26267 · latest filing Jul 2012
- Cipla LimitedIndiaCEP Company GMP cert on recordInactive DMF 20168 · latest filing Mar 2008
- SwitzerlandCEP
- FRESENIUS KABI ONCOLOGY LTDIndiaCEP Company GMP cert on recordInactive DMF 19610 · latest filing Jul 2006
- ChinaCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (14)
Certificates of Suitability on the EDQM register for Oxaliplatin, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 30 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| HETERO LABS LIMITED Hyderabad | IN | CEP 2015-112 - Rev 02 Oxaliplatin | Jun 2026 | — |
| SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai | IN | CEP 2024-552 - Rev 01 Oxaliplatin, Process-II | Mar 2026 | — |
| SHANDONG BOYUAN PHARMACEUTICAL CO., LTD. Jinan City | CN | CEP 2013-113 - Rev 01 Oxaliplatin | Nov 2025 | — |
| DEBIOPHARM INTERNATIONAL S.A. Lausanne | CH | CEP 2003-229 - Rev 06 Oxaliplatin | Jun 2025 | — |
| HERAEUS PRECIOUS METALS GMBH & CO. KG Hanau | DE | CEP 2006-137 - Rev 06 Oxaliplatin, Process HER-2 | Apr 2025 | Inspected Oct 2025 Germany |
| TAPI NL B.V. Amsterdam | NL | CEP 2005-259 - Rev 04 Oxaliplatin | Mar 2025 | — |
| LAURUS LABS LIMITED Hyderabad | IN | CEP 2011-357 - Rev 04 Oxaliplatin, Process 2 | Sept 2024 | — |
| KUNMING GUIYAN PHARMACEUTICAL CO., LTD. Kunming | CN | CEP 2009-384 - Rev 03 Oxaliplatin | Aug 2024 | — |
| JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. Lianyungang | CN | CEP 2024-149 - Rev 00 Oxaliplatin, Process II | Aug 2024 | — |
| FRESENIUS KABI ONCOLOGY LIMITED Kalyani | IN | CEP 2007-193 - Rev 06 Oxaliplatin | Jun 2024 | — |
| UMICORE ARGENTINA S.A. Pilar Industrial Park | AR | R0-CEP 2022-346 - Rev 00 Oxaliplatin, LB | Nov 2022 | — |
| SHILPA PHARMA LIFESCIENCES LIMITED Raichur | IN | R1-CEP 2006-201 - Rev 02 Oxaliplatin | Jul 2022 | — |
| QILU PHARMACEUTICAL CO., LTD. Jinan | CN | R1-CEP 2010-071 - Rev 03 Oxaliplatin | Sept 2021 | — |
| CIPLA LIMITED Mumbai | IN | R1-CEP 2007-296 - Rev 02 Oxaliplatin | Jul 2019 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (7)
Organisations whose Type II DMFs for Oxaliplatin are no longer active. These show a past filing, not current supply.
Show all 7 historical records
- China · Inactive DMF 27762 · filed Dec 2013
- MAC CHEM PRODUCTS INDIA PVT LTDInactive DMF 27028 · filed Apr 2013
- Hubei Haosun Pharmaceutical Co., Ltd.China · Inactive DMF 26107 · filed May 2012
- JARI PHARMACEUTICAL CO LTDInactive DMF 25681 · filed Jan 2012
- United States · Inactive DMF 24367 · filed Nov 2010
- India · Inactive DMF 23101 · filed Sept 2009
- POLYMED THERAPEUTICS INCInactive DMF 20897 · filed Sept 2007
Overview
Oxaliplatin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL414804).
Chemical identity
- IUPAC name
- oxalate;platinum(2+);trans-(1R,2R)-cyclohexane-1,2-diamine
- Canonical SMILES
- C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)[O-])[O-].[Pt+2]
- InChIKey
- ZROHGHOFXNOHSO-BNTLRKBRSA-L
- Synonyms
- Eloxatin, JM-83, L-OHP, MBP-426 (LIPOSOMAL OXALIPLATIN), NSC-266046, Oxaliplatin, Oxaliplatin component of folfox, Oxaliplatin component of xelox, Oxaliplatine, Oxaliplatino, RP-54780, SR-96669
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Platinum-based Drug
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Oxaliplatin?
19 organisations hold an active US FDA Type II Drug Master File or a CEP for Oxaliplatin: KUNMING GUIYAN PHARMACEUTICAL CO LTD (China), HERAEUS PRECIOUS METALS GMBH AND CO KG (Germany), Hetero Labs Limited (India), JIANGSU HENGRUI PHARMACEUTICALS CO LTD (China), Laurus Labs Limited (India), Qilu Pharmaceutical Co., Ltd. (China), SHILPA PHARMA LIFESCIENCES LTD (India) and Sun Pharmaceutical Industries Limited (India), and 11 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Oxaliplatin Drug Master Files are active?
KUNMING GUIYAN PHARMACEUTICAL CO LTD (DMF 41028, 29430), HERAEUS PRECIOUS METALS GMBH AND CO KG (DMF 19633), Hetero Labs Limited (DMF 28913), JIANGSU HENGRUI PHARMACEUTICALS CO LTD (DMF 20665), Laurus Labs Limited (DMF 22387), Qilu Pharmaceutical Co., Ltd. (DMF 23530), SHILPA PHARMA LIFESCIENCES LTD (DMF 23563) and Sun Pharmaceutical Industries Limited (DMF 19648) and 7 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Oxaliplatin records mean?
7 organisations have only inactive Type II DMFs for Oxaliplatin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Oxaliplatin have a European Certificate of Suitability?
Yes. 14 organisations hold a valid CEP for Oxaliplatin on the EDQM register, including HETERO LABS LIMITED Hyderabad (IN), SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai (IN), SHANDONG BOYUAN PHARMACEUTICAL CO., LTD. Jinan City (CN), DEBIOPHARM INTERNATIONAL S.A. Lausanne (CH), HERAEUS PRECIOUS METALS GMBH & CO. KG Hanau (DE) and TAPI NL B.V. Amsterdam (NL) and 8 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Oxaliplatin supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Oxaliplatin?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.